Search research articles
Contact Us
Filters
Showing results (161-170 of 242) with videos related to
Page
of 25
Sort By:
Plos One
|
September 30, 2010
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease
Paola Krall, Cesar P Canales, Pamela Kairath, et al.
American Journal of Physiology. Renal Physiology
|
January 15, 2015
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis
Namiko Kobayashi, Toshiharu Ueno, Kumi Ohashi, et al.
Scientific Reports
|
April 30, 2021
Application of regularized regression to identify novel predictors of mortality in a cohort of hemodialysis patients
Stanislas Werfel, Georg Lorenz, Bernhard Haller, et al.
American Journal of Human Genetics
|
March 1, 2011
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy
Nadine Norton, Duanxiang Li, Mark J Rieder, et al.
Journal of the American Heart Association
|
February 25, 2020
Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
Anurag Mehta, Shivang R Desai, Yi-An Ko, et al.
Journal of the American Society of Nephrology : JASN
|
December 15, 2006
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease
Clemens C Möller, Changli Wei, Mehmet M Altintas, et al.
Science Translational Medicine
|
September 20, 2023
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease
Ke Zhu, Kamalika Mukherjee, Changli Wei, et al.
The Journal of Biological Chemistry
|
June 20, 2008
Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity
Björn Hartleben, Heiko Schweizer, Pauline Lübben, et al.
Ebiomedicine
|
October 14, 2021
Deiodinase-3 is a thyrostat to regulate podocyte homeostasis
Shivangi Agarwal, Kwi Hye Koh, Nicholas J Tardi, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 16, 2018
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD
Shengyuan Luo, Josef Coresh, Adrienne Tin, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 242) with videos related to
Sort By:
Page
of 25
Plos One
|
September 30, 2010
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease
Paola Krall, Cesar P Canales, Pamela Kairath, et al.
American Journal of Physiology. Renal Physiology
|
January 15, 2015
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis
Namiko Kobayashi, Toshiharu Ueno, Kumi Ohashi, et al.
Scientific Reports
|
April 30, 2021
Application of regularized regression to identify novel predictors of mortality in a cohort of hemodialysis patients
Stanislas Werfel, Georg Lorenz, Bernhard Haller, et al.
American Journal of Human Genetics
|
March 1, 2011
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy
Nadine Norton, Duanxiang Li, Mark J Rieder, et al.
Journal of the American Heart Association
|
February 25, 2020
Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
Anurag Mehta, Shivang R Desai, Yi-An Ko, et al.
Journal of the American Society of Nephrology : JASN
|
December 15, 2006
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease
Clemens C Möller, Changli Wei, Mehmet M Altintas, et al.
Science Translational Medicine
|
September 20, 2023
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease
Ke Zhu, Kamalika Mukherjee, Changli Wei, et al.
The Journal of Biological Chemistry
|
June 20, 2008
Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity
Björn Hartleben, Heiko Schweizer, Pauline Lübben, et al.
Ebiomedicine
|
October 14, 2021
Deiodinase-3 is a thyrostat to regulate podocyte homeostasis
Shivangi Agarwal, Kwi Hye Koh, Nicholas J Tardi, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 16, 2018
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD
Shengyuan Luo, Josef Coresh, Adrienne Tin, et al.
Page
of 25